Differentiation induction in myelodysplasia and acute myeloid leukaemia: Use of synergistic drug combinations
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 11 (11) , 971-977
- https://doi.org/10.1016/0145-2126(87)90115-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The myelodysplastic syndromesClinical and Laboratory Haematology, 2008
- A randomized trial of 13‐cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndromeBritish Journal of Haematology, 1987
- The expected effect of a combination of agents: the general solutionJournal of Theoretical Biology, 1985
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Control of cell differentiation during proliferation — II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changesLeukemia Research, 1985
- Induction of differentiation in HL60 leukaemic cells: A cell cycle dependent all-or-none eventLeukemia Research, 1984
- Low Doses of Cytarabine in the Treatment of Myelodysplastic Syndrome and Acute Myeloid LeukemiaNew England Journal of Medicine, 1983
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaBritish Journal of Haematology, 1983
- Control of cell differentiation during proliferationExperimental Cell Research, 1983
- Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemiaLeukemia Research, 1983